Tiotropium/Salmeterol Inhalation Powder in COPD

NCT00668772 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium/Salmeterol
DRUG: Tiotropium/Salmeterol QD + Salmeterol
DRUG: Placebo
DRUG: Salmeterol
DRUG: Tiotropium

Sponsor

Boehringer Ingelheim